Rule 8.3 - INVERNESS MEDICAL INNOVATIONS INC
FORM 8.3
DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE
(Rule 8.3 of the City Code on Takeovers and Mergers)
1. KEY INFORMATION
Name of person dealing BARCLAYS PLC
(Note 1)
Company dealt in INVERNESS MEDICAL INNOVATIONS INC
Class of relevant security COM STK USD0.001
to which the dealings being
disclosed relate (Note 2)
Date of dealing 06 August 2009
2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
(1) Relevant 2,215,136 2.75% 137,026 0.17%
securities
(2) Derivatives 0 0.00%
(other than
options)
(3) Options and 148,300 0.18% 154,300 0.19%
agreements to
purchase/sell
Total 2,363,436 2.94% 291,326 0.36%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of Long Short
relevant
security:
Number (%) Number (%)
(1) Relevant
securities
(2) Derivatives
(other than
options)
(3) Options and
agreements to
purchase/sell
Total
(c) Rights to subscribe (Note 3)
Class of relevant security: Details
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of Securities Price per unit
(GBP)
Purchase 1,364 33.11281525
Purchase 1,888 33.59
Purchase 22 33.2000 USD
Purchase 768 33.2000 USD
Purchase 914 33.1230 USD
Purchase 1,078 33.2000 USD
Purchase 1,700 33.07547059
Purchase 3,009 33.0855899
Purchase 2,393 33.07016298
Purchase 200 33.22
Purchase 92 33.18
Purchase 300 33.16333333
Purchase 100 33.05
Purchase 4,900 33.05
Purchase 928 33.59
Purchase 3,634 33.13758943
Purchase 699 33.16852647
Purchase 311 33.2
Purchase 200 33.15
Purchase 401 33.19004988
Purchase 400 33.17575
Purchase 1,700 33.18411765
Purchase 800 33.1
Purchase 300 33.15
Purchase 100 33.18
Purchase 1,198 33.2
Purchase 800 33.115
Purchase 730 33.1585
Purchase 900 33.1233
Purchase 330 33.14
Purchase 9,100 33.11362637
Purchase 500 33.222
Purchase 400 33.085
Purchase 235 33.59
Purchase 300 34.37
Purchase 308 33.2
Purchase 200 34.39
Purchase 600 33.09666667
Purchase 1,600 33.07125
Purchase 200 33.235
Purchase 100 33.09
Purchase 100 33.3
Purchase 10,396 33.02829677
Purchase 200 33.01
Purchase 1,600 33.1034875
Purchase 100 33.3
Purchase 1,000 33.147
Purchase 600 33.13
Sale 300 33.15
Sale 500 33.164
Sale 2,000 33.07295
Sale 225 33.09333333
Sale 200 33.01
Sale 300 33.07
Sale 1,000 34.284
Sale 100 34.259
Sale 200 33.175
Sale 330 33.14
Sale 930 33.13623656
Sale 200 33.105
Sale 44 33.2000 USD
Sale 700 33.09142857
Sale 1,198 33.59
Sale 100 33.21
Sale 100 33.3
Sale 800 33.115
Sale 500 33.1192
Sale 100 34.46
Sale 4,600 33.1124
Sale 234 33.5043
Sale 900 33.1233
Sale 730 33.1585
Sale 200 33.01
Sale 777 33.59
Sale 1,076 33.59
Sale 100 33.011
Sale 100 33.16
Sale 92 33.18
Sale 600 33.01
Sale 5,000 33.05
Sale 546 33.2000 USD
Sale 7,066 33.00647608
Sale 84 33.2000 USD
Sale 22,500 33.1038
Sale 400 33
Sale 500 33.0272
Sale 1,908 33.2000 USD
Sale 1,481 33.0846 USD
Sale 1,480 33.2000 USD
Sale 1,004 33.0901 USD
Sale 924 33.2000 USD
Sale 700 33.0767 USD
Sale 210 33.2000 USD
Sale 136 33.2000 USD
Sale 475 33.07421053
(b) Derivatives transactions (other than options)
Product name, Long/Short Number of Price per
(e.g. CFD) (Note 6) Securities unit (GBP)
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name, Writing, Number of Exercise Type, e.g. Expiry Option money
e.g. call selling, securities to price American, date paid/received
option purchasing, which the option European etc. per unit (GBP)
varying etc. relates (GBP)
(ii) Exercising
Product name, e.g. Number of Exercise price per
call option securities unit (Note 5)
(d) Other dealings (including new securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
4. OTHER INFORMATION
None
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the
person disclosing and any other person relating to the voting rights of
any relevant securities under any option referred to on this form or
relating to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred to on this form is
referenced. If none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9) YES
Date of disclosure 07 August 2009
Contact name Geoff Smith
Telephone number 020 7116 2913
If a connected EFM, name of
offeree/offeror with which connected
If a connected EFM, state nature of
connection (Note 10)
Notes
The Notes on Form 8.3 can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
SUPPLEMENTAL FORM 8
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1, Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name, Written or Number of securities Exercise price Type, e.g. Expiry date
e.g. call option purchased to which the option (Note 2) American,
or derivative relates European etc.
Option Purchased -2,900 55.0000 AMER 22/01/2011
Option Purchased -39,600 40.0000 AMER 22/08/2009
Option Purchased -200 35.0000 AMER 21/11/2009
Option Purchased -200 25.0000 AMER 20/02/2010
Option Purchased -400 35.0000 AMER 22/01/2011
Option Purchased -500 20.0000 AMER 22/08/2009
Option Purchased -700 40.0000 AMER 16/01/2010
Option Purchased -800 40.0000 AMER 20/02/2010
Option Purchased -1,400 30.0000 AMER 22/01/2011
Option Purchased -1,900 30.0000 AMER 21/11/2009
Option Purchased -2,000 22.5000 AMER 22/08/2009
Option Purchased -2,100 25.0000 AMER 22/01/2011
Option Purchased -100 17.5000 AMER 22/08/2009
Option Purchased -2,800 25.0000 AMER 16/01/2010
Option Purchased -100 22.5000 AMER 22/01/2011
Option Purchased -3,000 35.0000 AMER 20/02/2010
Option Purchased -4,300 50.0000 AMER 22/01/2011
Option Purchased -4,400 55.0000 AMER 16/01/2010
Option Purchased -4,600 25.0000 AMER 16/01/2010
Option Purchased -4,700 40.0000 AMER 21/11/2009
Option Purchased -5,200 35.0000 AMER 16/01/2010
Option Purchased -9,100 35.0000 AMER 19/09/2009
Option Purchased -10,400 30.0000 AMER 22/08/2009
Option Purchased -10,900 30.0000 AMER 22/08/2009
Option Purchased -16,000 40.0000 AMER 19/09/2009
Option Purchased -23,600 25.0000 AMER 22/08/2009
Option Purchased -2,200 35.0000 AMER 22/08/2009
Option Purchased 600 35.0000 AMER 21/11/2009
Option Purchased 22,400 25.0000 AMER 22/08/2009
Option Purchased 6,900 30.0000 AMER 16/01/2010
Option Purchased 4,700 35.0000 AMER 22/08/2009
Option Purchased 4,700 20.0000 AMER 16/01/2010
Option Purchased 4,200 30.0000 AMER 16/01/2010
Option Purchased 2,700 45.0000 AMER 21/11/2009
Option Purchased 2,600 50.0000 AMER 16/01/2010
Option Purchased 2,500 45.0000 AMER 16/01/2010
Option Purchased 1,800 40.0000 AMER 22/01/2011
Option Purchased 1,600 30.0000 AMER 21/11/2009
Option Purchased 1,600 25.0000 AMER 19/09/2009
Option Purchased -100 17.5000 AMER 16/01/2010
Option Purchased 900 35.0000 AMER 16/01/2010
Option Purchased 87,900 35.0000 AMER 22/08/2009
Option Purchased 600 22.5000 AMER 22/08/2009
Option Purchased 400 50.0000 AMER 21/11/2009
Option Purchased 300 40.0000 AMER 21/11/2009
Option Purchased 200 15.0000 AMER 22/01/2011
Option Purchased 100 35.0000 AMER 20/02/2010
Option Purchased 100 22.5000 AMER 22/01/2011
Option Purchased 100 20.0000 AMER 16/01/2010
Option Purchased 100 17.5000 AMER 22/01/2011
Option Purchased 100 15.0000 AMER 16/01/2010
Option Purchased 100 12.5000 AMER 22/01/2011
Option Purchased -100 25.0000 AMER 21/11/2009
Option Purchased 1,100 20.0000 AMER 22/08/2009
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given.
Full details of any existing agreements to purchase or to sell should also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the Takeover
Panel's website at www.thetakeoverpanel.org.uk